Anti-GGTA1P monoclonal antibody

Pre-made anti-GGTA1P monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GGTA1P/GGTA1P products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0903-Ab-1/ GM-Tg-hg-IP0903-Ab-2Anti-Human GGTA1P monoclonal antibodyHuman
GM-Tg-rg-IP0903-Ab-1/ GM-Tg-rg-IP0903-Ab-2Anti-Rat GGTA1P monoclonal antibodyRat
GM-Tg-mg-IP0903-Ab-1/ GM-Tg-mg-IP0903-Ab-2Anti-Mouse GGTA1P monoclonal antibodyMouse
GM-Tg-cynog-IP0903-Ab-1/ GM-Tg-cynog-IP0903-Ab-2Anti-Cynomolgus/ Rhesus macaque GGTA1P monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0903-Ab-1/ GM-Tg-felg-IP0903-Ab-2Anti-Feline GGTA1P monoclonal antibodyFeline
GM-Tg-cang-IP0903-Ab-1/ GM-Tg-cang-IP0903-Ab-2Anti-Canine GGTA1P monoclonal antibodyCanine
GM-Tg-bovg-IP0903-Ab-1/ GM-Tg-bovg-IP0903-Ab-2Anti-Bovine GGTA1P monoclonal antibodyBovine
GM-Tg-equg-IP0903-Ab-1/ GM-Tg-equg-IP0903-Ab-2Anti-Equine GGTA1P monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0903-Ab-1/ GM-Tg-hg-IP0903-Ab-2; GM-Tg-rg-IP0903-Ab-1/ GM-Tg-rg-IP0903-Ab-2;
GM-Tg-mg-IP0903-Ab-1/ GM-Tg-mg-IP0903-Ab-2; GM-Tg-cynog-IP0903-Ab-1/ GM-Tg-cynog-IP0903-Ab-2;
GM-Tg-felg-IP0903-Ab-1/ GM-Tg-felg-IP0903-Ab-2; GM-Tg-cang-IP0903-Ab-1/ GM-Tg-cang-IP0903-Ab-2;
GM-Tg-bovg-IP0903-Ab-1/ GM-Tg-bovg-IP0903-Ab-2; GM-Tg-equg-IP0903-Ab-1/ GM-Tg-equg-IP0903-Ab-2
Products NameAnti-GGTA1P monoclonal antibody
Formatmab
Target NameGGTA1P
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GGTA1P monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0903-Ag-1Recombinant multi-species GGTA1/ GGTA1P/ GGTA protein
    ORF Viral VectorpGMAAV000049mouse Ggta1 AAV plasmid
    ORF Viral VectorvGMAAV000049mouse Ggta1 AAV particle


    Target information

    Target IDGM-IP0903
    Target NameGGTA1P
    Gene ID2681,14594,246766,100426461,491357,493877
    Gene Symbol and Synonymsa1/3GTP,alpha Gal,alpha3GalT,Gal,GALT,GGTA,Ggta-1,GGTA1,GGTA1P,GLYT2
    Uniprot AccessionQ4G0N0,Q3L7M0,Q8HY56
    Uniprot Entry NameGGTA1_HUMAN,GGTA1_RAT,GGTA1_FELCA
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000204136
    Target ClassificationN/A

    The target: GGTA1P, gene name: GGTA1P, also named as GGTA, GGTA1, GLYT2, a1/3GTP. Alpha-1,3-galactosyltransferase (GGTA1) is an enzyme present in most mammals except man, apes, and Old World monkeys. This gene is thought to encode a truncated, non-enzymatic form of the GGTA1 protein that lacks the C-terminal catalytic domain. Aberrant expression of the GGTA1 protein in man can lead to autoimmune diseases and sometimes germ cell tumors. [provided by RefSeq, May 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.